Valuation: Macrogen, Inc.

Market Cap 119B 88.78M 79.11M 72.55M 65.93M 124M 8.39B 127M 867M 348M 4.44B 333M 326M 14.07B P/E 2026 *
14.7x
P/E 2027 * 7.41x
Enterprise Value 196M 146K 130K 119K 108K 204K 13.79M 208K 1.43M 571K 7.3M 548K 536K 23.13M EV / Sales 2026 *
0.94x
EV / Sales 2027 * 0.75x
Free-Float
79.78%
Yield 2026 *
4.55%
Yield 2027 * 4.55%
1 day+0.27%
1 week-2.14%
Current month+0.92%
1 month-12.63%
3 months-7.33%
6 months-32.18%
Current year-34.80%
1 week 10,600
Extreme 10600
11,230
1 month 10,600
Extreme 10600
12,620
Current year 10,440
Extreme 10440
20,900
1 year 10,440
Extreme 10440
20,900
3 years 10,440
Extreme 10440
26,700
5 years 10,440
Extreme 10440
31,250
10 years 10,440
Extreme 10440
54,900
Manager TitleAgeSince
Chief Executive Officer 59 30/03/2025
Chief Executive Officer 53 30/03/2026
Chief Executive Officer 74 30/03/2025
Director TitleAgeSince
Chairman 74 09/10/2010
Director/Board Member 59 -
Director/Board Member 53 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
09/04/25 Buy

Chief Executive Officer

1,100 0.0101%
07/02/25 Others 2,192 0.0202%
23/01/25 Others

Chief Financial Officer

95 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+0.27%-2.14%-27.63%-36.16% 88.54M
+3.80%+8.47%+64.65%+77.70% 66.87B
+1.63%+4.93%+24.89%+102.90% 56.55B
+0.07%+1.39%+12.75%+76.61% 57.2B
+0.35%-3.85%+25.87%+33.30% 43.47B
-6.46%-0.02%+220.58%+783.15% 42.8B
+3.91%+5.68%+22.18%+100.19% 42.95B
+1.59%-4.04%+97.66%+81.57% 32.11B
+7.50%+13.28%+28.05%+64.46% 34.01B
-2.34%-2.89%-42.01%+354.57% 24.13B
Average +1.04%+3.67%+42.70%+163.83% 40.02B
Weighted average by Cap. +1.28%+3.91%+52.60%+170.01%

Financials

2026 *2027 *
Net sales 208B 155M 138M 127M 115M 216M 14.66B 221M 1.51B 607M 7.76B 582M 570M 24.57B 245B 182M 163M 149M 135M 255M 17.24B 260M 1.78B 714M 9.12B 685M 670M 28.9B
Net income 8.1B 6.03M 5.37M 4.93M 4.48M 8.42M 570M 8.61M 58.9M 23.61M 302M 22.63M 22.15M 955M 16.1B 11.99M 10.68M 9.79M 8.9M 16.73M 1.13B 17.12M 117M 46.93M 600M 44.99M 44.03M 1.9B
Net Debt 76.8B 57.17M 50.95M 46.72M 42.46M 79.82M 5.4B 81.65M 558M 224M 2.86B 215M 210M 9.06B 64.8B 48.24M 42.99M 39.42M 35.83M 67.35M 4.56B 68.89M 471M 189M 2.41B 181M 177M 7.64B
Projected Income Statement - Annual - Macrogen, Inc.
Logo Macrogen, Inc.
Macrogen Inc is a Korea-based company principally engaged in the genome analysis business. The Company’s main products include DNA sequencing, oligo synthesis, and microarray analysis. The Company also provides various genome-based research services such as single-cell analysis and metagenome analysis. In addition, the Company is engaged in the operation of genetically engineered mouse production, clinical genome analysis services, personal genome analysis services, and microbiome analysis services. The Company sells its products and services in domestic and overseas markets.
Employees
473
Date Price Change Volume
04/11/26 ₩11,000.00 +0.27% 11,683
04/11/26 ₩10,970.00 +1.01% 15,535
03/11/26 ₩10,860.00 -1.27% 12,027
02/11/26 ₩11,000.00 +0.92% 13,280
30/10/26 ₩10,900.00 -0.46% 10,630
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Macrogen, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10,970.00KRW
Average target price
21,000.00KRW
Spread / Average Target
+91.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Macrogen, Inc.
  1. Stock Market
  2. Stocks
  3. A038290 Stock